Monitor for continued insider selling in the next 30 days; isolated transactions at this level are routine, but a pattern could signal reduced confidence. The non-cash grants are standard compensation and not actionable.
Price Chart
Executive Summary
Seven insiders at Madrigal Pharmaceuticals, including the CEO, CFO, and other C-suite executives, conducted open-market sales and stock awards within a 7-day window. The total value of open-market sales was approximately $2.37 million, representing modest insider selling activity at a company with a $10.1 billion market cap.
Key Financial Metrics
Key Facts
- CEO William Sibold sold $718,316 worth of shares in open-market transactions on March 6, 2026.
- CFO Mardi Dier sold $505,389 worth of shares on March 2, 2026.
- Four other C-suite executives sold shares totaling $1.15 million on March 6.
- Five insiders received non-cash stock awards totaling 27,375 shares on March 4, 2026.
- Total open-market selling amounted to $2.37 million over 7 days.
- Selling represents ~0.023% of the company's $10.1 billion market capitalization.
Financial Impact
$2.37 million in open-market insider sales over 7 days, representing 0.023% of market cap
Risk Factors
- Perception of insider profit-taking following a potential price run-up
- Risk of negative sentiment if selling continues in coming weeks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (9 trades, 7d window) | cluster-MDGL-1772840985473 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | 8-K | $536.20 $533.12 | ▼ −0.57% | ▲ +1.32% | $496.64 (−7.38%) |
Jul 30, 2026 9w ago | 8-K | $493.11 $543.69 | ▲ +10.26% | ▲ +6.29% | $496.64 (+0.71%) |
May 22, 2026 18w ago | Insider Cluster | $524.28 $520.00 | ▼ −0.82% | ▲ +1.13% | $496.64 (−5.27%) |
May 6, 2026 21w ago | 8-K | $539.73 $488.15 | ▼ −9.56% | ▼ −12.34% | $496.64 (−7.98%) |
Apr 28, 2026 22w ago | 8-K | $518.58 $515.96 | ▼ −0.51% | ▼ −6.55% | $496.64 (−4.23%) |
Apr 22, 2026 23w ago | Press Release | $529.14 $511.82 | ▼ −3.27% | ▼ −6.44% | $496.64 (−6.14%) |
Mar 19, 2026 28w ago | Press Release | $441.16 $527.11 | ▲ +19.48% | ▲ +10.16% | $496.64 (+12.57%) |
Mar 2, 2026 30w ago | Insider Cluster | $435.62 $505.34 | ▲ +16.00% | ▲ +23.94% | $496.64 (+14.01%) |
Mar 2, 2026 30w ago | Insider Cluster | $435.62 $505.34 | ▲ +16.00% | ▲ +23.94% | $496.64 (+14.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access